BR0308052A - Sais benzoato de (2's,3s)-3-hidróxi-n-{2-[n-metil-n-4-(n-propilamino-carb onil)fenil]amino-2-fenil}etilpirrolidina cristalinos anidros e mono-hidratos - Google Patents
Sais benzoato de (2's,3s)-3-hidróxi-n-{2-[n-metil-n-4-(n-propilamino-carb onil)fenil]amino-2-fenil}etilpirrolidina cristalinos anidros e mono-hidratosInfo
- Publication number
- BR0308052A BR0308052A BR0308052-8A BR0308052A BR0308052A BR 0308052 A BR0308052 A BR 0308052A BR 0308052 A BR0308052 A BR 0308052A BR 0308052 A BR0308052 A BR 0308052A
- Authority
- BR
- Brazil
- Prior art keywords
- phenyl
- monohydrates
- hydroxy
- amino
- methyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
"SAIS BENZOATO DE (2<39>S,3S)-3-HIDRóXI-N-{2-[N-METIL-N-4-(N-PROPILAMINO-CA RBONIL)FENIL]AMINO-2-FENIL}ETIL-PIRROLIDINA CRISTALINOS ANIDROS E MONO-HIDRATOS". A presente invenção refere-se a um processo de preparação de um sal benzoato anidro na forma cristalina possuindo a fórmula I: e o correspondente mono-hidrato de benzoato na forma cristalina. Os sais benzoato e suas composições farmacêuticas são agonistas de receptor capa seletivos, e são úteis como agentes analgésicos, anestésicos, antiinflamatórios ou neuroprotetores, ou no tratamento da artrite, derrame cerebral ou doença funcional do intestino.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36025002P | 2002-02-28 | 2002-02-28 | |
PCT/IB2003/000560 WO2003072544A1 (en) | 2002-02-28 | 2003-02-17 | Crystalline anhydrous and monohydrate benzoate salts of (2's,3s)-3-hydroxy-n-{2{n-methyl-n-4-(n-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0308052A true BR0308052A (pt) | 2004-12-28 |
Family
ID=27766206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0308052-8A BR0308052A (pt) | 2002-02-28 | 2003-02-17 | Sais benzoato de (2's,3s)-3-hidróxi-n-{2-[n-metil-n-4-(n-propilamino-carb onil)fenil]amino-2-fenil}etilpirrolidina cristalinos anidros e mono-hidratos |
Country Status (8)
Country | Link |
---|---|
US (1) | US7038061B2 (pt) |
EP (1) | EP1478622A1 (pt) |
JP (1) | JP2005519084A (pt) |
AU (1) | AU2003248351A1 (pt) |
BR (1) | BR0308052A (pt) |
CA (1) | CA2477634A1 (pt) |
MX (1) | MXPA04008352A (pt) |
WO (1) | WO2003072544A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003269399A1 (en) * | 2002-11-01 | 2004-05-25 | Pfizer Products Inc. | Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TNSN97092A1 (ar) * | 1996-09-18 | 1999-12-31 | Agouron Pharma | مثبطات انزيم بروتيني فلزي وتركيبات صيدلانية تحتوي على تلك المثبتطات واستخدامها الصيدلاني وطرق ومركبات وسيطة مفيدة لتحضير التركيبات المذكورة. |
WO2002088082A2 (en) * | 2001-04-30 | 2002-11-07 | Pfizer Products Inc. | Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists |
-
2003
- 2003-02-17 MX MXPA04008352A patent/MXPA04008352A/es unknown
- 2003-02-17 EP EP03742880A patent/EP1478622A1/en not_active Withdrawn
- 2003-02-17 BR BR0308052-8A patent/BR0308052A/pt not_active IP Right Cessation
- 2003-02-17 AU AU2003248351A patent/AU2003248351A1/en not_active Abandoned
- 2003-02-17 WO PCT/IB2003/000560 patent/WO2003072544A1/en not_active Application Discontinuation
- 2003-02-17 JP JP2003571250A patent/JP2005519084A/ja active Pending
- 2003-02-17 CA CA002477634A patent/CA2477634A1/en not_active Abandoned
- 2003-04-23 US US10/421,209 patent/US7038061B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2003248351A1 (en) | 2003-09-09 |
EP1478622A1 (en) | 2004-11-24 |
US7038061B2 (en) | 2006-05-02 |
WO2003072544A1 (en) | 2003-09-04 |
US20040235936A1 (en) | 2004-11-25 |
CA2477634A1 (en) | 2003-09-04 |
MXPA04008352A (es) | 2004-11-26 |
JP2005519084A (ja) | 2005-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2868777A1 (fr) | Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable | |
BR0011324A (pt) | Agonista de adrenoceptores beta 2 | |
HRP20160808T4 (hr) | Kristalni paptidi epoksiketona kao inhibitori proteaze i sinteza ketoepoksidnih aminokiselina | |
BR0210711A (pt) | Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto | |
BR0314611A (pt) | Compostos de tiazol para o tratamento de distúrbios neurodegenerativos | |
PT1326613E (pt) | Utilizacao de derivados de imidazo[1,2-a]piridin-,imidazo[1,2-a]pirimidin- e imidazo[1,2-a]pirazin-3-il-amina substituidos para a fabricacao de medicamentos para inibicao de nos | |
GT200500060A (es) | Compuestos de imidazol para el tratamiento de trastornos neurodegenerativos | |
BRPI0811280B8 (pt) | compostos amino-heterocíclicos, composição farmacêutica que os compreende e usos dos referidos compostos | |
BRPI0416656A (pt) | compostos de pirrolopirimidina úteis no tratamento do cáncer | |
BR0210384A (pt) | Heteroarilas multicìclicas substituìdas por quinuclidinas para o tratamento de doença | |
BRPI0500393A (pt) | Processo para a sìntese e forma cristalina de agomelatina e composições farmacêuticas contendo-a | |
BR112013029240A2 (pt) | derivados deuterados do ivacaftor | |
BRPI0409624A (pt) | 2-hidróxi-3-diaminoalcanos de benzamida | |
BRPI0415683A (pt) | inibidores da reabsorção de norepinefrina para o tratamento de distúrbios do sistema nervoso central | |
BRPI0413245A (pt) | compostos heteroarila de 6 membros para o tratamento de distúrbio neurodegenerativos | |
EA200870302A1 (ru) | 1,3-диоксанкарбоновые кислоты | |
BRPI0507334A (pt) | processo para a preparação de -1(2s,3s)-2-benzidril-n-(5-terc-butil-2-metoxibenzila)q uinuclidin-3-amina | |
BRPI0411891A (pt) | pirazol[3,4-b]piridin-6-onas como inibidores de gsk-3 | |
BRPI0413709A (pt) | compostos para o tratamento de distúrbios neurodegenerativos | |
BRPI0411122A (pt) | pirazol[3,4-b]piridin-6-onas como inibidores gsk-3 | |
BR0313727A (pt) | Derivados de isoquinolina como inibidores de metaloproteinase da matriz | |
AR065477A1 (es) | Diaminopirimidinas | |
DE602007013040D1 (de) | 4-Ä(3-FLUORPHENOXY)PHENYLMETHYLÜPIPERIDINMETHANiSULFONAT: VERWENDUNGEN, SYNTHESEVERFAHREN UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN | |
BRPI0513647A (pt) | derivados de ácidos 1-fenilalcanocarboxìlicos para o tratamento de doenças neurodegenerativas | |
DK1670903T3 (da) | Behandling af neurodegenerative sygdomme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 5A., 6A., E 7A., ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010. |